LivaNova Recalls Blood Pump Device for Risk of Unintentional Extended Pump Stop
LivaNova is recalling the LifeSPARC Controller due to a software update being available to address a previous software malfunction.
LivaNova is recalling the LifeSPARC Controller due to a software update being available to address a previous software malfunction.
The FDA approved Abbott’s new transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis.
As a biomed, bringing your talent to a developing world hospital that is struggling for sound medical equipment can be an intensely satisfying experience. For those who are thinking about making a medical mission trip to the developing world for the first time, partnering with an organization that can help prepare supplies and contacts is key to a successful experience.
Smiths Medical has issued an Urgent Medical Device Correction Letter for two potential issues with CADD infusion system infusion sets.
Invictus Medical has submitted a De Novo application to the FDA for its Neoasis incubator-based active noise control device.
Currently valued at $14.9 billion, the global anesthesia devices market is slated to exhibit a compound annual growth rate of 7.6% by 2030.
The FDA is providing additional information to patients, caregivers, and healthcare providers about two recent issues in certain ventilators.